Biolife Sciences (Biolife Sciences) Additional Paid-In Capital : $4.76 Mil(As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Additional Paid-In Capital?

Biolife Sciences's quarterly additional paid-in capital increased from Nov. 2007 ($3.95 Mil) to Feb. 2008 ($4.13 Mil) and increased from Feb. 2008 ($4.13 Mil) to May. 2008 ($4.76 Mil).

Biolife Sciences's annual additional paid-in capital increased from Nov. 2005 ($1.86 Mil) to Nov. 2006 ($2.13 Mil) and increased from Nov. 2006 ($2.13 Mil) to Nov. 2007 ($3.95 Mil).

Biolife Sciences Additional Paid-In Capital Historical Data

The historical data trend for Biolife Sciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Additional Paid-In Capital Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Additional Paid-In Capital

0.12

1.86

2.13

3.95

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Additional Paid-In Capital	Get a 7-Day Free Trial										2.73	3.09	3.95	4.13	4.76

Biolife Sciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Biolife Sciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020